Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Expands By 6,463.0%

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 1,368,917 shares, a growth of 6,463.0% from the August 15th total of 20,858 shares. Currently, 2.3% of the shares of the company are sold short. Based on an average daily volume of 4,230,483 shares, the short-interest ratio is currently 0.3 days.

Azitra Price Performance

Shares of NYSEAMERICAN:AZTR opened at $0.18 on Friday. The business has a 50 day moving average of $0.15 and a two-hundred day moving average of $0.19. Azitra has a 12-month low of $0.10 and a 12-month high of $1.09.

Azitra (NYSEAMERICAN:AZTR) last announced its earnings results on Wednesday, August 12th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.05). As a group, equities analysts anticipate that Azitra will post -0.25 earnings per share for the current year.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.